Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease
CONCLUSION: Oral antiviral agents could be associated with lower rates of all-cause hospitalization or death among non-hospitalized COVID-19 patients with CKD.PMID:38525673 | DOI:10.1080/14787210.2024.2334052
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Chia-Chen Chen Chi-Ya Huang Jheng-Yan Wu Mei-Yuan Liu Min-Hsiang Chuang Ting-Hui Liu Ya-Wen Tsai Wan-Hsuan Hsu Po-Yu Huang Ming-Hui Chen Su-Yen Liu Mei-Chuan Lee Kuo-Chuan Hung Chih-Cheng Lai I-Ning Yang Source Type: research
More News: Chia | Chronic Kidney Disease | Covid Vaccine | COVID-19 | Infectious Diseases | Norvir | Study | Urology & Nephrology | Vaccines